All UAB investigators and staff involved in clinical trials, regardless of funding source, are required to meet the NIH policy regarding GCP training for basic GCP training and refresher GCP training ...
Prior authorization remains a major barrier to biologic access in AD. Dr Chuck Vega covers denial rates, appeal outcomes, and the clinical data that make the fight worthwhile.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results